Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P53675 (
CHC22
)
19
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The muscle isoform of clathrin heavy chain,
CHC22
, has 85% sequence identity to the ubiquitously expressed
CHC17
, yet its expression pattern and function appear to be distinct from those of well-characterized clathrin-coated vesicles. In mature muscle
CHC22
is preferentially concentrated at neuromuscular and myotendinous junctions, suggesting a role at sarcolemmal contacts with extracellular matrix. During myoblast differentiation,
CHC22
expression is increased, initially localized with desmin and nestin and then preferentially segregated to the poles of fused myoblasts.
CHC22
expression is also increased in regenerating muscle fibers with the same time course as embryonic myosin, indicating a role in muscle repair.
CHC22
binds to sorting nexin 5 through a coiled-coil domain present in both partners, which is absent in
CHC17
and coincides with the region on
CHC17
that binds the regulatory light-chain subunit. These differential binding data suggest a mechanism for the distinct functions of
CHC22
relative to
CHC17
in membrane traffic during muscle development, repair, and at neuromuscular and myotendinous junctions.
...
PMID:Clathrin isoform CHC22, a component of neuromuscular and myotendinous junctions, binds sorting nexin 5 and has increased expression during myogenesis and muscle regeneration. 1513 32
In humans, there are two isoforms each of clathrin heavy chain (
CHC17
and
CHC22
) and light chain (LCa and LCb) subunits, all encoded by separate genes.
CHC17
forms the ubiquitous clathrin-coated vesicles that mediate membrane traffic.
CHC22
is implicated in specialized membrane organization in skeletal muscle.
CHC17
is bound and regulated by LCa and LCb, whereas
CHC22
does not functionally interact with either light chain. The imbalanced interactions between clathrin subunit isoforms suggest a distinct evolutionary history for each isoform pair. Phylogenetic and sequence analysis placed both heavy and light chain gene duplications during chordate evolution, 510-600 million years ago. Genes encoding
CHC22
orthologues were found in several vertebrate species, with only a pseudogene present in mice. Multiple paralogons surrounding the
CHC
genes (CLTC and CLTD) were identified, evidence that genomic or large-scale gene duplication produced the two
CHC
isoforms. In contrast, clathrin light chain genes (CLTA and CLTB) apparently arose by localized duplication, within 1-11 million years of
CHC
gene duplication. Analysis of sequence divergence patterns suggested that structural features of the CHCs were maintained after gene duplication, but new interactions with regulatory proteins evolved for the
CHC22
isoform. Thus, independent mechanisms of gene duplication expanded clathrin functions, concomitant with development of neuromuscular sophistication in chordates.
...
PMID:Clathrin heavy and light chain isoforms originated by independent mechanisms of gene duplication during chordate evolution. 1588 69
Clathrin is crucial for endocytosis and plays a recently described role in mitosis. Two clathrin heavy chains (CHCs) are found in humans: the ubiquitous
CHC17
, and
CHC22
, a CHC that is enriched in skeletal muscle. Functional differences have been proposed for these clathrins despite high sequence similarity. Here, we compared each paralogue in functional assays of endocytosis and mitosis. We find that
CHC17
and
CHC22
are functionally equivalent. We also describe how previous work on
CHC22
has involved a splice variant that is not usually expressed in cells.
...
PMID:Functional equivalence of the clathrin heavy chains CHC17 and CHC22 in endocytosis and mitosis. 1950 56
Clathrin is considered the prototype vesicle coat protein whose self-assembly mediates sorting of membrane cargo and recruitment of lipid modifiers. Detailed knowledge of clathrin biochemistry, structure, and interacting proteins has accumulated since the first observation, almost 50 years ago, of its role in receptor-mediated endocytosis of yolk protein. This review summarizes that knowledge, and focuses on properties of the clathrin heavy and light chain subunits and interaction of the latter with Hip proteins, to address the diversity of clathrin function beyond conventional receptor-mediated endocytosis. The distinct functions of the two human clathrin isoforms (
CHC17
and
CHC22
) are discussed, highlighting
CHC22
's specialized involvement in traffic of the GLUT4 glucose transporter and consequent role in human glucose metabolism. Analysis of clathrin light chain function and interaction with the actin-binding Hip proteins during bacterial infection defines a novel actin-organizing function for
CHC17
clathrin. By considering these diverse clathrin functions, along with intracellular sorting roles and influences on mitosis, further relevance of clathrin function to human health and disease is established.
...
PMID:Diversity of clathrin function: new tricks for an old protein. 2283 40
Clathrin depletion by ribonucleic acid interference (RNAi) impairs mitotic spindle stability and cytokinesis. Depletion of several clathrin-associated proteins affects centrosome integrity, suggesting a further cell cycle function for clathrin. In this paper, we report that RNAi depletion of
CHC17
(clathrin heavy chain 17) clathrin, but not the
CHC22
clathrin isoform, induced centrosome amplification and multipolar spindles. To stage clathrin function within the cell cycle, a cell line expressing SNAP-tagged clathrin light chains was generated. Acute clathrin inactivation by chemical dimerization of the SNAP-tag during S phase caused reduction of both clathrin and ch-TOG (colonic, hepatic tumor overexpressed gene) at metaphase centrosomes, which became fragmented. This was phenocopied by treatment with Aurora A kinase inhibitor, suggesting a centrosomal role for the Aurora A-dependent complex of clathrin, ch-TOG, and TACC3 (transforming acidic coiled-coil protein 3). Clathrin inactivation in S phase also reduced total cellular levels of ch-TOG by metaphase. Live-cell imaging showed dynamic clathrin recruitment during centrosome maturation. Therefore, we propose that clathrin promotes centrosome maturation by stabilizing the microtubule-binding protein ch-TOG, defining a novel role for the clathrin-ch-TOG-TACC3 complex.
...
PMID:Clathrin promotes centrosome integrity in early mitosis through stabilization of centrosomal ch-TOG. 2294 20
Mobilization of the GLUT4 glucose transporter from intracellular storage vesicles provides a mechanism for insulin-responsive glucose import into skeletal muscle. In humans, clathrin isoform
CHC22
participates in formation of the GLUT4 storage compartment in skeletal muscle and fat.
CHC22
function is limited to retrograde endosomal sorting and is restricted in its tissue expression and species distribution compared to the conserved
CHC17
isoform that mediates endocytosis and several other membrane traffic pathways. Previously, we noted that
CHC22
was expressed at elevated levels in regenerating rat muscle. Here we investigate whether the GLUT4 pathway in which
CHC22
participates could play a role in muscle regeneration in humans and we test this possibility using
CHC22
-transgenic mice, which do not normally express
CHC22
. We observed that GLUT4 expression is elevated in parallel with that of
CHC22
in regenerating skeletal muscle fibers from patients with inflammatory and other myopathies. Regenerating human myofibers displayed concurrent increases in expression of VAMP2, another regulator of GLUT4 transport. Regenerating fibers from wild-type mouse skeletal muscle injected with cardiotoxin also showed increased levels of GLUT4 and VAMP2. We previously demonstrated that transgenic mice expressing
CHC22
in their muscle over-sequester GLUT4 and VAMP2 and have defective GLUT4 trafficking leading to diabetic symptoms. In this study, we find that muscle regeneration rates in
CHC22
mice were delayed compared to wild-type mice, and myoblasts isolated from these mice did not proliferate in response to glucose. Additionally,
CHC22
-expressing mouse muscle displayed a fiber type switch from oxidative to glycolytic, similar to that observed in type 2 diabetic patients. These observations implicate the pathway for GLUT4 transport in regeneration of both human and mouse skeletal muscle, and demonstrate a role for this pathway in maintenance of muscle fiber type. Extrapolating these findings,
CHC22
and GLUT4 can be considered markers of muscle regeneration in humans.
...
PMID:The CHC22 clathrin-GLUT4 transport pathway contributes to skeletal muscle regeneration. 2420 66
Clathrin self-assembles into a coat around vesicles filled with cargo such as nutrients, hormones, and proteins destined for degradation. Recent developments indicate clathrin is not a specialist, but is involved in different processes relevant to health and disease. Clathrin is used to strengthen centrosomes and mitotic spindles essential for chromosome segregation in cell division. In Wnt signaling, clathrin is a component of signalosomes on the plasma membrane needed to produce functional Wnt receptors. In glucose metabolism, a muscle-specific isoform,
CHC22
clathrin, is key to the formation of storage compartments for GLUT4 receptor, and
CHC22
dysfunction has been tied to type 2 diabetes. The activity of clathrin to self-assemble and to work with huntingtin-interacting proteins to organize actin is exploited by Listeria and enteropathic Escherichia coli in their infection pathways. Finally, there is an important connection between clathrin and human malignancies. Clathrin is argued to help transactivate tumor suppressor p53 that controls specific genes in DNA repair and apoptosis. However, this is debatable because trimeric clathrin must be made monomeric. To get insight on how the clathrin structure could be converted, the crystal structure of the trimerization domain is used in the development of the detrimerization switch hypothesis. This novel hypothesis will be relevant if connections continue to be found between
CHC17
and p53 anti-cancer activity in the nucleus.
...
PMID:Novel clathrin activity: developments in health and disease. 2537 51
Clathrins are cytoplasmic proteins that play essential roles in endocytosis and other membrane traffic pathways. Upon recruitment to intracellular membranes, the canonical clathrin triskelion assembles into a polyhedral protein coat that facilitates vesicle formation and captures cargo molecules for transport. The triskelion is formed by trimerization of three clathrin heavy-chain subunits. Most vertebrates have two isoforms of clathrin heavy chains,
CHC17
and
CHC22
, generating two clathrins with distinct cellular functions.
CHC17
forms vesicles at the plasma membrane for receptor-mediated endocytosis and at the trans-Golgi network for organelle biogenesis.
CHC22
plays a key role in intracellular targeting of the insulin-regulated glucose transporter 4 (GLUT4), accumulates at the site of GLUT4 sequestration during insulin resistance, and has also been implicated in neuronal development. Here, we demonstrate that
CHC22
and
CHC17
share morphological features, in that
CHC22
forms a triskelion and latticed vesicle coats. However, cellular
CHC22
-coated vesicles were distinct from those formed by
CHC17
. The
CHC22
coat was more stable to pH change and was not removed by the enzyme complex that disassembles the
CHC17
coat. Moreover, the two clathrins were differentially recruited to membranes by adaptors, and
CHC22
did not support vesicle formation or transferrin endocytosis at the plasma membrane in the presence or absence of
CHC17
. Our findings provide biochemical evidence for separate regulation and distinct functional niches for
CHC17
and
CHC22
in human cells. Furthermore, the greater stability of the
CHC22
coat relative to the
CHC17
coat may be relevant to its excessive accumulation with GLUT4 during insulin resistance.
...
PMID:CHC22 and CHC17 clathrins have distinct biochemical properties and display differential regulation and function. 2909 53
The repertoire of cell types in the human nervous system arises through a highly orchestrated process, the complexity of which is still being discovered. Here, we present evidence that
CHC22
has a non-redundant role in an early stage of neural precursor differentiation, providing a potential explanation of why
CHC22
deficient patients are unable to feel touch or pain. We show the
CHC22
effect on neural differentiation is independent of the more common clathrin heavy chain
CHC17
, and that
CHC22
-dependent differentiation is mediated through an autocrine/paracrine mechanism. Using quantitative proteomics, we define the composition of clathrin-coated vesicles in SH-SY5Y cells, and determine proteome changes induced by
CHC22
depletion. In the absence of
CHC22
a subset of dense core granule (DCG) neuropeptides accumulated, were processed into biologically active 'mature' forms, and secreted in sufficient quantity to trigger neural differentiation. When
CHC22
is present, however, these DCG neuropeptides are directed to the lysosome and degraded, thus preventing differentiation. This suggests that the brief reduction seen in
CHC22
expression in sensory neural precursors may license a step in neuron precursor neurodevelopment; and that this step is mediated through control of a novel neuropeptide processing pathway.
...
PMID:Clathrin heavy chain 22 contributes to the control of neuropeptide degradation and secretion during neuronal development. 2940 96
CHC22
clathrin plays a key role in intracellular membrane traffic of the insulin-responsive glucose transporter GLUT4 in humans. We performed population genetic and phylogenetic analyses of the
CHC22
-encoding
CLTCL1
gene, revealing independent gene loss in at least two vertebrate lineages, after arising from gene duplication. All vertebrates retained the paralogous
CLTC
gene encoding
CHC17
clathrin, which mediates endocytosis. For vertebrates retaining
CLTCL1
, strong evidence for purifying selection supports
CHC22
functionality. All human populations maintained two high frequency
CLTCL1
allelic variants, encoding either methionine or valine at position 1316. Functional studies indicated that
CHC22
-V1316, which is more frequent in farming populations than in hunter-gatherers, has different cellular dynamics than M1316-
CHC22
and is less effective at controlling GLUT4 membrane traffic, altering its insulin-regulated response. These analyses suggest that ancestral human dietary change influenced selection of allotypes that affect
CHC22
's role in metabolism and have potential to differentially influence the human insulin response.
...
PMID:Genetic diversity of CHC22 clathrin impacts its function in glucose metabolism. 3115 24
1